Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02242097
Title Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

mantle cell lymphoma

Therapies

Ibrutinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
Northwestern University- Lake Forest Hospital Lake Forest Illinois 60045 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Utah Salt Lake City Utah 84132 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field